5 tips to reduce the liability risk of prescribing GLP-1s

Signing bonus repayment, malpractice tail coverage, lopsided notice periods and unpaid productivity pay can make leaving an employed position expensive. An analysis of 200 physician contracts shows what to check before you sign.

Only 22 of the articles in a Georgetown scoping review defined health equity, a gap the lead author said could steer resources toward the most advantaged groups.

Key findings from the AMGA 2026 Medical Clinic Staffing Survey

Learn what a work RVU is, how Medicare's 2027 conversion factor turns RVUs into payment and how employers use wRVUs to set physician compensation.

Is the time coming for primary care to move beyond traditional insurance? It’s worth a conversation, said a leader of the American Academy of Family Physicians.

Higher Part D deductibles, rising Medigap and Part B premiums and the end of $0-premium drug plans may lead patients to skip refills and visits early in 2027. Here’s who is most exposed, why lower utilization could mask 2028 costs and what to do before Dec. 7 and in January.

The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.

In a controlled test of 12 AI models across 33 physician-written clinical cases, a clearly labeled pharmaceutical ad raised the share of responses choosing the advertised drug from 35% to 47.6%.